Take Solutions Ltd

₹ 21.8 -0.46%
01 Jul - close price
About

Founded in 2001 as a software services provider, TAKE is currently a technology driven, full service Clinical Research Organization. It helps biopharma companies throughout the drug development process, and beyond. Headquartered in Chennai, India, it has a global footprint spanning the Americas, Europe and the Asia Pacific region.
The co. delivers domain-intensive services in Life Sciences.
TAKE is the only full-service technology-driven Clinical Research Organization listed in India.
It has 1,70,000 regulatory submissions and submitted 5% of all regulatory submissions to USFDA 2012 to 2020.[1] [1] [2] [3]

Key Points

Services
Life Sciences (94% of revenue in FY20): TAKE assists drug companies in bringing their products to the market and helps them sustain the drugs throughout their market life cycle.
Clinical Trials: It assists drug companies in conducting clinical trials of new drugs, aimed at evaluating their safety and efficacy.
Regulatory Affairs: it assists in the documentation and submission process of data and insights gathered at each stage of the drug development process to the regulatory bodies at predefined intervals.
Supply Chain Management (6% of revenue in FY 20): The Company's Supply Chain business in India is a JV with APA Engineering. [1] [2] [3]

  • Market Cap 323 Cr.
  • Current Price 21.8
  • High / Low 69.6 / 20.6
  • Stock P/E
  • Book Value 12.2
  • Dividend Yield 0.00 %
  • ROCE -79.5 %
  • ROE -120 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Debtor days have improved from 121.86 to 45.40 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -13.39% over past five years.
  • Company has a low return on equity of -28.90% for last 3 years.
  • Contingent liabilities of Rs.848.84 Cr.
  • Company's cost of borrowing seems high
  • Promoter holding has decreased over last 3 years: -13.48%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
583 608 651 371 166 171 216 221 209 197 207 41
473 502 543 526 212 248 211 179 178 174 225 764
Operating Profit 110 106 108 -155 -46 -77 5 42 31 24 -18 -723
OPM % 19% 17% 17% -42% -28% -45% 2% 19% 15% 12% -8% -1,754%
1 6 3 16 -153 3 10 -68 3 2 9 3
Interest 10 10 11 10 10 9 9 8 11 8 9 2
Depreciation 45 40 41 40 30 29 28 28 25 26 23 6
Profit before tax 55 62 60 -190 -240 -113 -23 -62 -3 -7 -41 -728
Tax % 16% 18% 15% 16% -0% -3% -13% -10% -28% -22% -3% -0%
Net Profit 45 50 50 -158 -242 -116 -25 -68 -3 -9 -42 -728
EPS in Rs 3.05 3.38 3.41 -10.68 -16.36 -7.81 -1.72 -4.60 -0.22 -0.60 -2.83 -49.23

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
500 704 832 816 730 1,030 1,345 1,587 2,039 2,213 774 655
397 559 670 668 581 817 1,082 1,281 1,655 2,044 847 1,341
Operating Profit 103 145 161 147 149 213 262 307 384 169 -73 -686
OPM % 21% 21% 19% 18% 20% 21% 20% 19% 19% 8% -9% -105%
6 15 7 6 8 21 13 6 11 26 -211 17
Interest 8 18 14 14 13 15 23 21 25 41 37 29
Depreciation 22 27 46 77 60 74 87 104 154 167 115 80
Profit before tax 80 115 107 63 85 145 165 188 216 -13 -437 -779
Tax % 8% 18% 17% 2% 6% 14% 11% 15% 17% 15% -3% -0%
Net Profit 70 86 79 58 70 120 143 160 177 -12 -452 -782
EPS in Rs 5.72 6.99 6.49 4.74 5.71 9.78 10.74 10.85 11.99 -0.84 -30.56 -52.88
Dividend Payout % 17% 14% 15% 21% 17% 10% 9% 15% 8% -0% -0% -0%
Compounded Sales Growth
10 Years: -1%
5 Years: -13%
3 Years: -32%
TTM: -15%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -236%
Stock Price CAGR
10 Years: -5%
5 Years: -34%
3 Years: -44%
1 Year: -67%
Return on Equity
10 Years: -3%
5 Years: -11%
3 Years: -29%
Last Year: -120%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
12 12 12 12 12 12 13 15 15 15 15 15
Reserves 243 330 408 458 512 619 898 1,314 1,504 1,561 1,110 166
185 193 196 207 209 336 237 323 474 553 514 65
147 206 220 185 189 246 221 189 339 336 187 977
Total Liabilities 588 741 837 862 922 1,214 1,369 1,840 2,331 2,465 1,826 1,223
267 339 368 384 359 543 554 589 1,091 1,234 934 101
CWIP 4 1 3 2 17 3 21 42 41 1 0 3
Investments 50 50 50 50 6 21 10 59 10 18 7 -0
266 351 415 426 541 647 785 1,150 1,188 1,213 885 1,119
Total Assets 588 741 837 862 922 1,214 1,369 1,840 2,331 2,465 1,826 1,223

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
59 115 117 100 74 151 56 121 104 211 135
-201 -81 -70 -91 -14 -292 -130 -179 -474 -233 -57
141 -21 -31 -7 -11 111 56 302 100 21 -84
Net Cash Flow -1 13 16 2 49 -30 -18 243 -270 -2 -6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 76 82 99 100 120 107 118 108 94 116 205 45
Inventory Days
Days Payable
Cash Conversion Cycle 76 82 99 100 120 107 118 108 94 116 205 45
Working Capital Days 68 55 71 83 121 107 136 143 142 137 289 49
ROCE % 21% 26% 21% 12% 14% 17% 17% 15% 13% 1% -9% -80%

Shareholding Pattern

Numbers in percentages

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
66.89 66.89 66.89 66.89 58.65 53.41 53.41 53.41 53.41 53.41 53.41 53.41
11.19 10.20 10.32 10.26 9.61 4.62 1.92 1.72 1.61 1.55 1.38 0.84
2.20 2.36 2.32 2.34 2.03 1.35 1.14 1.13 0.27 0.28 0.28 0.28
19.73 20.55 20.47 20.51 29.72 40.62 43.53 43.74 44.71 44.76 44.93 45.47

Documents

Concalls